Nonfatal myocardial infarction occurred in 2.3% of patients treated with oral semaglutide and 1.9% treated with placebo (HR 1.18, 95% CI 0.731.90), nonfatal stroke occurred in 0.8% versus 1.0% treated with placebo (HR 0.74, 95% CI 0.351.57), and death from cardiovascular causes occurred in 0.9% versus 1.9% treated with placebo (HR 0.51, 95% CI 0.310.84)
Similar content being viewed by others Introduction The regenerative capacity of the liver remains the single most relevant factor determining postoperative outcome after hepatic resection, as post-hepatectomy liver failure (PHLF) remains the most frequent cause of mortality after partial hepatectomy 1
Delaying the blood test by even a few weeks can push your surgical date back
GLP-1 therapies have gained significant attention in the health and wellness community, particularly for their role in weight management and diabetes control
To prevent this, our program prioritizes lifestyle educationteaching you how to eat and move in ways that support your new weight in the long term
H., Jensen, C
